Details of the Drug

General Information of Drug (ID: DM8J5H1)

Drug Name

PRLX93936

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1/2	[1]

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Voltage-dependent anion-selective channel 3 (VDAC3)	TTT48SQ	VDAC3_HUMAN	Modulator	[2]

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT01695590) Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma. U.S. National Institutes of Health.
2	Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.